SOLICITATION NOTICE
66 -- Brand Name Only Fetal Bovine Serum, CAT# SH30071.03IR from the required LOT#’s - Terms & Conditions - Brnd Name Only
- Notice Date
- 8/10/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 5601 Fishers Lane, 3rd Floor MSC 9822, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- RFQ-RML-E-1865268
- Archive Date
- 8/19/2017
- Point of Contact
- Jesse Weidow, , Janna Weber,
- E-Mail Address
-
weidowjd@niaid.nih.gov, janna.weber@nih.gov
(weidowjd@niaid.nih.gov, janna.weber@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Brnd Name Only Terms & Conditions FedBizOps Synopsis Document Type: Combined Synopsis/Solicitation Solicitation Number: RFQ-RML-E-1865268 Posted Date: 08/10/2017 Response Date: 08/18/2017 Set Aside: none NAICS Code: 325414 Classification Code: 66 Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive MSC 4811 Room 2NE70-A, Bethesda, MD 20817 Title: Brand Name Only Fetal Bovine Serum, CAT# SH30071.03IR from the required LOT#'s listed below. Primary Point of Contact: Secondary Point of Contact Jesse Weidow Janna Weber Description: This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-RML-E-1865268 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-95 January 1/2017 The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing, with a small business size standard of 1250 employees. The small business set aside is dissolved for this requirement. The acquisition is being competed full and open with brand name restriction. The National Institute of Allergy and Infectious Diseases (NIAID) Laboratory of Infectious Disease has a brand name requirement for Fetal Bovine Serum CAT# SH30071.03IR from the specific LOT#'s listed below, to support of ongoing research. BRAND NAME AND SPECIFIC LOT# ONLY: Quantity of 250 CAT# SH30071.03IR 500ML all from LOT# AC102196360 Quantity of 30 CAT# SH30071.03IR 500ML all from LOT# DZK0498 Offeror must submit certificate of analysis, proof of US origin for the US origin characterized FBS, and proof of origin for the NZ characterized FBS, and a sample to be tested for suitability in our lab. Offer must also include shipping costs as well as ETA. Place of Performance: NIH, 50 South Drive, Bethesda, MD 20892, United States. FOB: Destination. The government intends to a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; price, capability to meet the requirements, delivery and the best value to the government. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2014) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2015) Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Dec 2014) is updated in your SAM record) FAR 52.222-22 Previous Contract and Compliance Reports (Feb 1999) FAR 52.222-25 Affirmative Action Compliance (April 1984) FAR 52.204-16 Commercial and Government Entity Code Reporting (Nov 2014) FAR 52.204-7 System for Award Management (July 2013) FAR 52.203-98 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02) The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (Jan 2017) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2017) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.203-99 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Feb 2015) FAR 52.204-18 Commercial and Government Entity Code Maintenance (Nov 2014) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (July 2013) FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010) By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. To facilitate the award process all quotes must include a statement regarding the terms and conditions herein as follows: "The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" (Quoter shall list exception(s) and rationale for the exception(s).) Submission shall be received not later than 08/18/17 by 10:00 Eastern time. Offers may be mailed, e-mailed to Jesse Weidow, (E-Mail/ jesse.weidow@nih.gov). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Jesse Weidow @ jesse.weidow@nih.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/RFQ-RML-E-1865268/listing.html)
- Place of Performance
- Address: 50 South Drive, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04622074-W 20170812/170810231619-32ef8fd017a5e19d6e61367fd60efab4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |